IronBridge Capital Management’s Celgene Corp CELG Stock Holding History

IronBridge Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$17.3M	Sell	139,271 -141,219	-50%	-$16.9M	1.05%	24
2016 Q4	$32.5M	Buy	280,490 +276,650	+7,204%	+$30.8M	1.45%	18
2016 Q3	$401K	Buy	3,840 +640	+20%	+$69.3K	0.02%	163
2016 Q2	$316K	Buy	+3,200	New	+$331K	0.01%	171
2014 Q1	–	Sell	-5,524	Closed	-$467K	–	224
2013 Q4	$467K	Sell	5,524 -4,746	-46%	-$376K	0.01%	200
2013 Q3	$791K	Hold	10,270	–	–	0.02%	199
2013 Q2	$601K	Buy	+10,270	New	+$618K	0.01%	206

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IronBridge Capital Management's CELG Position: Q1 2017 in Review

IronBridge Capital Management reduced its Celgene Corp (CELG) stake by 50% in Q1 2017, selling an estimated $16.9M and leaving 139,271 shares worth $17.3M. The position accounts for 1.05% of the portfolio, ranked #24.

IronBridge Capital Management first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. The position peaked at $32.5M in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

IronBridge Capital Management held 139,271 shares of Celgene Corp worth $17.3M as of Q1 2017.
IronBridge Capital Management sold 141,219 Celgene Corp shares in Q1 2017, an estimated $16.9M.
Celgene Corp made up 1.05% of IronBridge Capital Management's portfolio in Q1 2017, its #24 holding.
IronBridge Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
IronBridge Capital Management's Celgene Corp position peaked at $32.5M in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.